Request Deal Involvement

Al Hammadi Company for Development and Investment to acquire a 35% stake in Sudair Pharmaceuticals from Gulf Investment for $32m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jones Day

legal advisors

Jones Day

King & Spalding

legal advisors

King & Spalding

or

Principals

SUDAIR PHARMACEUTICALS

target

SUDAIR PHARMACEUTICALS

AL HAMMADI COMPANY FOR DEVELOPMENT AND INVESTMENT

bidder

AL HAMMADI COMPANY FOR DEVELOPMENT AND INVESTMENT

GULF INVESTMENT CORPORATION

vendor

GULF INVESTMENT CORPORATION

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Al Hammadi Company for Development and Investment to acquire a 35% stake in Sudair Pharmaceuticals from Gulf Investment for $32m.